{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:00:53Z","timestamp":1762272053643},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"name":"Ministry of Health, Labour"},{"name":"Welfare, a Grant for National Center"},{"name":"Global Health and Medicine"},{"name":"Japan Agency for Medical Research and Development (AMED)"},{"DOI":"10.13039\/501100012629","name":"Japan Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012629","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1093\/jac\/dkw224","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T17:09:16Z","timestamp":1466701756000},"page":"2760-2766","source":"Crossref","is-referenced-by-count":7,"title":["Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations"],"prefix":"10.1093","volume":"71","author":[{"given":"Tsunefusa","family":"Hayashida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Hachiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Ode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoto","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,6,20]]},"reference":[{"key":"2016092200323784000_71.10.2760.1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2013.03.014","article-title":"HIV-1 reverse transcriptase and antiviral drug resistance. Part 2","volume":"2","author":"Das","year":"2013","journal-title":"Curr Opin Virol"},{"key":"2016092200323784000_71.10.2760.2","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.2174\/092986712803833326","article-title":"Structure\u2013activity relationship studies on clinically relevant HIV-1 NNRTIs","volume":"31","author":"Rawal","year":"2012","journal-title":"Curr Med Chem"},{"key":"2016092200323784000_71.10.2760.3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3122-3126.2004"},{"key":"2016092200323784000_71.10.2760.4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01032-06"},{"key":"2016092200323784000_71.10.2760.5","unstructured":"EACS European AIDS Clinical Society Guidelines, Version 8.0, October 2015 . http:\/\/www.eacsociety.org\/files\/2015_eacsguidelines_8.0-english_rev-20151221.pdf ."},{"key":"2016092200323784000_71.10.2760.6","unstructured":"DHHS Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents . 28 January 2016. https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf ."},{"key":"2016092200323784000_71.10.2760.7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt316"},{"key":"2016092200323784000_71.10.2760.8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04215-14"},{"key":"2016092200323784000_71.10.2760.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60936-7"},{"key":"2016092200323784000_71.10.2760.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60983-5"},{"key":"2016092200323784000_71.10.2760.11","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31823aca74"},{"key":"2016092200323784000_71.10.2760.12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit430"},{"key":"2016092200323784000_71.10.2760.13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328337b010"},{"key":"2016092200323784000_71.10.2760.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.11.012"},{"key":"2016092200323784000_71.10.2760.15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01480-09"},{"key":"2016092200323784000_71.10.2760.16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M505920200"},{"key":"2016092200323784000_71.10.2760.17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711209105"},{"key":"2016092200323784000_71.10.2760.18","first-page":"132","article-title":"2015 update of the drug resistance mutations in HIV-1","volume":"23","author":"Wensing","year":"2015","journal-title":"Top Antivir Med"},{"key":"2016092200323784000_71.10.2760.19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ963"},{"key":"2016092200323784000_71.10.2760.20","doi-asserted-by":"publisher","DOI":"10.1038\/nature07746"},{"key":"2016092200323784000_71.10.2760.21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02572-12"},{"key":"2016092200323784000_71.10.2760.22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401419"},{"key":"2016092200323784000_71.10.2760.23","doi-asserted-by":"publisher","DOI":"10.1038\/35085576"},{"key":"2016092200323784000_71.10.2760.24","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1128\/JVI.74.22.10269-10273.2000","article-title":"Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites","volume":"74","author":"Brown","year":"2000","journal-title":"J Virol"},{"key":"2016092200323784000_71.10.2760.25","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00303-07"},{"key":"2016092200323784000_71.10.2760.26","doi-asserted-by":"publisher","DOI":"10.2174\/1874357900701010008"},{"key":"2016092200323784000_71.10.2760.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00423-9"},{"key":"2016092200323784000_71.10.2760.28","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb758"},{"key":"2016092200323784000_71.10.2760.29","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku256"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/10\/2760\/7077436\/dkw224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:57:27Z","timestamp":1589673447000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,20]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,9,22]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1093\/jac\/dkw224"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw224","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,20]]}}}